The risk factors for hepatic steatosis in patients with primary aldosteronism
| Autor: | Norio Wada, Shinji Obara, Tatsuya Atsumi, Hidetsugu Sakai, Satoshi Terae, Akinobu Nakamura, Yui Shibayama, Hiroaki Usubuchi, Shuhei Baba |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Intra-Abdominal Fat Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Blood Pressure Gastroenterology 03 medical and health sciences 0302 clinical medicine Endocrinology Primary aldosteronism Japan Risk Factors Internal medicine Hyperaldosteronism medicine Prevalence Humans Obesity Computed tomography Aldosterone Retrospective Studies Metabolic Syndrome business.industry Fatty liver Retrospective cohort study Middle Aged medicine.disease Fatty Liver 030220 oncology & carcinogenesis Hypertension Female Metabolic syndrome Steatosis business Non-alcoholic fatty liver disease |
| Zdroj: | Endocrine journal. 67(6) |
| ISSN: | 1348-4540 |
| Popis: | Patients with primary aldosteronism (PA) are complicated by metabolic syndrome more frequently than those without PA. Hyperaldosteronism has been reported to be associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD). We aimed to clarify the risk factors for hepatic steatosis in the two subtypes of PA, comparing the status of hepatic steatosis in each of these subtypes. This was a retrospective observational study. We enrolled patients with an aldosterone producing adenoma (APA) (n = 33) or idiopathic hyperaldosteronism (IHA) (n = 56). Hepatic fat content was evaluated using the ratio of liver to spleen (L/S) X-ray attenuation on unenhanced computed tomography. L/S ratio |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|